About Lumicell Diagnostics
Lumicell Diagnostics is a Healthcare company based in Wellesley (United States) founded in 2008 by Moungi Bawendi and W David Lee. Developer of fluorescence-guided imaging technologies to help surgeons detect residual cancer tissue during operations. Lumicell Diagnostics has raised $360.8 million across 19 funding rounds from investors including HHS, LaunchCapital and BlueIO. The company has 23 employees. Its chief executive, as recorded, is Howard Hechler. Lumicell Diagnostics offers products and services including LumiSystem, LUMISIGHT, and Lumicell DVS. Its focus areas include Life Sciences, Oncology, Medical Devices and Surgical Tools. Its competitors include Averto Medical, On Target Laboratories and US Medical Innovations; 3 of its 3 listed competitors have raised funding.
Company details
Lumicell Diagnostics was established in 2008 in Wellesley, United States, within the medical imaging sector. Fluorescence-guided systems are created to support surgeons in visualizing residual cancer tissue in real time during operations. Single-cell detection capabilities are integrated, enabling evaluation of the tumor bed after initial resection. Operations focus on oncology applications, with potential to lower recurrence rates and limit needs for follow-up radiation or chemotherapy.
- Headquarters Wellesley, United States
- Employees 23
- Founders Moungi Bawendi, W David Lee
- SectorsHealthcare
- Email••••••••
- Website lumicell.com
- Social LinkedIn X Facebook
- Total Equity Funding$360.8M (USD)
in 19 rounds
- Latest Funding Round$198.13M (USD), Series D
Apr 2025
- InvestorsHHS
& 3 more
- Employee Count23
Products & Services of Lumicell Diagnostics
Lumicell Diagnostics offers a comprehensive portfolio of products and services, including LumiSystem, LUMISIGHT, and Lumicell DVS.
Real-time system for detecting residual breast cancer during lumpectomy.
Agent that illuminates cancer for intraoperative visualization.
Technology for real-time cancer excision guidance in surgery.
Funding Insights of Lumicell Diagnostics
Lumicell Diagnostics has successfully raised a total of $360.8M across 19 strategic funding rounds. The most recent funding activity was a Series D round of $198.13 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $360.8M
- Total Rounds 19
- Last Round Series D — $198.13M
- First Round $147,505
(Dec 2010)
- Investors Count 4
Latest 10 of 19 funding rounds of Lumicell Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $198.13M | Series D | – | – | – |
| Jul 2024 | $2.73M | Series D | – | – | – |
| Jul 2024 | Debt – Conventional | – | – | – | |
| Jul 2024 | Debt – Conventional | – | – | – | |
| Feb 2024 | $2.28M | Series C | – | – | – |
| Jul 2023 | $75.84M | Series C | – | – | – |
| Dec 2018 | $20.37M | Series C | – | – | – |
| Dec 2017 | $28.7M | Series C | – | LaunchCapital, BlueIO | – |
| Oct 2017 | $20.71M | Series B | – | – | – |
| Jul 2016 | $1.97M | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Lumicell Diagnostics
Lumicell Diagnostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, LaunchCapital and BlueIO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in seed & early stage companies in the US | launchcapital.com | New Haven, United States | ||
Investments are made by BlueIO in early-stage technology companies. | blueio.co | Boston, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Lumicell Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lumicell Diagnostics
17 people are tracked at Lumicell Diagnostics (7 in leadership, 9 in board & advisors, 1 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Moungi Bawendi | Co-Founder | Leadership |
W David Lee | Co-Founder | Leadership |
Howard Hechler | Chief Executive Officer | Leadership |
Kevin Hershberger | President & CEO | Leadership |
Elisabeth Carroll | Vice President Human Resources | Leadership |
Daniel K. Harris | VP of Pharmaceutical Development & CMC | Leadership |
Brian Schlossberg, Ph.D. | Vice President, New Business Strategy and Innovation | Leadership |
Cosimo Fiorenza | Director | Board & advisors |
Andrey Zarur | Director | Board & advisors |
David Furneaux | Director | Board & advisors |
Kevin Krenitsky | Director | Board & advisors |
Ralph Weissleder | Director | Board & advisors |
Mike Ruettgers | Director | Board & advisors |
Linda Griffith | Scientific Advisor | Board & advisors |
Jeffrey M. Drazen | Scientific Advisor | Board & advisors |
David Kirsch | Scientific Advisor | Board & advisors |
Jorge Ferrer | SVP of Clinical Research & Strategy | Team |
Complete people profiles for Lumicell Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lumicell Diagnostics
3 dated milestones of Lumicell Diagnostics across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Lumicell Diagnostics is founded.
- Funding First funding round of $148K.
- Funding Latest funding round, Series D, of $198.1M.
Competitors of Lumicell Diagnostics
Lumicell Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Averto Medical, On Target Laboratories and US Medical Innovations.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avertomed.com | 2016 | Fremont, United States | $33M | 18 | Medical devices for gastrointestinal disease patients are developed. | |
| ontargetlabs.com | 2010 | West Lafayette, United States | $116.5M | 29 | Molecular imaging agents for cancer surgery are developed. | |
| usmedinnovations.com | 2010 | Takoma Park, United States | $11.18M | Electrosurgery and plasma technology for cancer treatment are developed. |
Detailed competitors of Lumicell Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lumicell Diagnostics
The website of Lumicell Diagnostics (lumicell.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▼ 15.2% vs previous month
Top companies in Oncology
3 companies that operate in the same segment as Lumicell Diagnostics (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lumicell Diagnostics
Complete news archive for Lumicell Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lumicell Diagnostics
Lumicell Diagnostics was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Lumicell Diagnostics is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Howard Hechler is the CEO of Lumicell Diagnostics, as recorded in our data.
Lumicell Diagnostics is a funded company, having raised a total of $360.8M across 19 funding rounds to date. The company's 1st funding round was a Grant of $1.97M, raised on Dec 2010.
Lumicell Diagnostics has 23 employees.
Lumicell Diagnostics was established in 2008 in Wellesley, United States, within the medical imaging sector. Fluorescence-guided systems are created to support surgeons in visualizing residual cancer tissue in real time during operations. Single-cell detection capabilities are integrated, enabling evaluation of the tumor bed after initial resection. Operations focus on oncology applications, with potential to lower recurrence rates and limit needs for follow-up radiation or chemotherapy.
Lumicell Diagnostics's top competitors include Averto Medical, On Target Laboratories and US Medical Innovations.
Lumicell Diagnostics offers LumiSystem, LUMISIGHT, and Lumicell DVS.
Lumicell Diagnostics has 4 investors. Key investors include HHS, LaunchCapital, BlueIO, and National Science Foundation.